Association between visit-to-visit variability of glycemic indices and lipid profile and the incidence of coronary heart disease in adults with type 2 diabetes.
Blood pressure
CHD
Coronary heart disease
Glycemic indices
HbA1c
Lipid profile
Type 2 diabetes mellitus
Variability
Journal
Journal of diabetes and metabolic disorders
ISSN: 2251-6581
Titre abrégé: J Diabetes Metab Disord
Pays: Switzerland
ID NLM: 101590741
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
12
07
2021
accepted:
23
10
2021
entrez:
13
12
2021
pubmed:
14
12
2021
medline:
14
12
2021
Statut:
epublish
Résumé
Coronary heart disease (CHD) is one of the major causes of mortality and morbidity in patients with type 2 diabetes mellitus. In this study, we aimed to assess the association between visit-to-visit variability of fasting blood sugar (FBS), HbA1c, blood sugar 2 h post-prandial (BS2hpp), lipid indices, creatinine, systolic and diastolic blood pressure (SBP, DBP) and incident CHD in patients with type 2 diabetes during a median follow-up of ten years. The current case-cohort study consisted of 1500 individuals with type 2 diabetes, followed up for the occurrence of CHD from 2002 to 2019. The patients had at least four annual follow-ups during which glycemic and lipid profile were measured. Co-efficient of variance (CV) for each parameter was calculated by 10-21 measurements. Cox regression analysis was performed to assess the association between CV of glycemic indices, lipid profile, blood pressure, creatinine, weight and incident CHD during the follow-up period. Hazard ratios (HR) were adjusted for the confounding variables. Glycemic indices variability (i.e., CV-HbA1c, CV-FBS, and CV-BS2hpp), were significantly higher in the group with incident CHD (P=0.034, P=0.042, and P=0.044, respectively). Hazard ratios were 1.42 (95 % CI=1.13-2.09) for CV-HbA1c, 1.37 (95 % CI=1.02-2.10) for CV-FBS, and 1.16 (95 % CI=1.01-1.63) for CV-BS2hpp (P=0.012, P=0.046, P=0.038, respectively). Creatinine was significantly higher in the group with incident CHD (P=0.036) and it was significantly associated with higher incidence of CHD (HR=1.14, 95 % CI=1.02-2.17, P=0.048). Visit to visit variability of glycemic indices of the patients with type 2 diabetes is associated with incident CHD independent of their baseline and mean values.
Identifiants
pubmed: 34900821
doi: 10.1007/s40200-021-00930-z
pii: 930
pmc: PMC8630209
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1715-1723Informations de copyright
© Springer Nature Switzerland AG 2021.
Déclaration de conflit d'intérêts
Conflict of interestNone.
Références
Aging Male. 2020 Dec;23(5):906-910
pubmed: 31156011
PLoS One. 2015 Jun 08;10(6):e0129265
pubmed: 26053836
QJM. 2015 Oct;108(10):781-7
pubmed: 25636343
Sci Rep. 2019 Feb 4;9(1):1374
pubmed: 30718626
Diabetol Metab Syndr. 2014 Jun 30;6:76
pubmed: 25013458
Eur Heart J. 2017 Dec 21;38(48):3560-3566
pubmed: 29069458
Swiss Med Wkly. 2019 Oct 27;149:w20139
pubmed: 31656034
JAMA. 2006 Apr 12;295(14):1681-7
pubmed: 16609090
JAMA. 2006 Apr 12;295(14):1707-8
pubmed: 16609094
Eur J Clin Invest. 2020 Mar;50(3):e13206
pubmed: 31999832
J Coll Physicians Surg Pak. 2018 Nov;28(11):844-847
pubmed: 30369376
Diabetes Care. 2015 Feb;38(2):249-56
pubmed: 25414153
Nutr Metab Cardiovasc Dis. 2010 Jan;20(1):15-21
pubmed: 19364638
Hypertension. 2018 Oct;72(4):1002-1010
pubmed: 30354707
Circulation. 2002 Oct 15;106(16):2067-72
pubmed: 12379575
Diabetes Care. 2007 Jan;30(1):162-72
pubmed: 17192355
Aging Male. 2020 Dec;23(5):1098-1102
pubmed: 31615320
Diabetes Obes Metab. 2020 Oct;22(10):1777-1788
pubmed: 32452623
J Hypertens Suppl. 1992 Aug;10(6):S73-7
pubmed: 1432333
Diabetes Obes Metab. 2019 Dec;21(12):2587-2598
pubmed: 31282073
Endocrinol Diabetes Metab. 2020 Jun 08;3(3):e00135
pubmed: 32704558
J Diabetes Metab Disord. 2017 Nov 14;16:45
pubmed: 29164077
Biochem Biophys Res Commun. 2006 Nov 10;350(1):195-201
pubmed: 16997277
Diabetes Care. 2019 Jan;42(1):134-141
pubmed: 30352898
Arch Ophthalmol. 1984 Apr;102(4):527-32
pubmed: 6367725
Circulation. 2005 Jul 5;112(1):25-31
pubmed: 15983251
J Diabetes Complications. 2006 Mar-Apr;20(2):75-80
pubmed: 16504835
J Am Coll Cardiol. 2015 Apr 21;65(15):1539-48
pubmed: 25881936
Rev Assoc Med Bras (1992). 2019 Jan;65(1):38-42
pubmed: 30758418
Diabetologia. 2009 May;52(5):952-61
pubmed: 19263033
Diabetes. 2008 May;57(5):1349-54
pubmed: 18299315
Bratisl Lek Listy. 2021;122(2):116-119
pubmed: 33502879
J Am Heart Assoc. 2017 Nov 29;6(12):
pubmed: 29187392
Cardiovasc Diabetol. 2018 Feb 24;17(1):33
pubmed: 29477146
Diabetes Care. 2009 Aug;32(8):1440-6
pubmed: 19401445
Curr Vasc Pharmacol. 2012 Nov;10(6):684-6
pubmed: 23259553
Cardiovasc Diabetol. 2016 May 21;15:79
pubmed: 27208906
N Engl J Med. 1991 Jun 27;324(26):1839-44
pubmed: 2041550
Atherosclerosis. 2015 Feb;238(2):370-9
pubmed: 25558032
Diabetes Metab Res Rev. 2008 Jul-Aug;24(5):353-63
pubmed: 18461635